Immunocore Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Immunocore Holdings has a total shareholder equity of $368.8M and total debt of $48.0M, which brings its debt-to-equity ratio to 13%. Its total assets and total liabilities are $597.0M and $228.2M respectively.
Key information
13.0%
Debt to equity ratio
US$48.01m
Debt
Interest coverage ratio | n/a |
Cash | US$442.63m |
Equity | US$368.84m |
Total liabilities | US$228.16m |
Total assets | US$597.00m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6YG's short term assets ($528.8M) exceed its short term liabilities ($139.0M).
Long Term Liabilities: 6YG's short term assets ($528.8M) exceed its long term liabilities ($89.1M).
Debt to Equity History and Analysis
Debt Level: 6YG has more cash than its total debt.
Reducing Debt: 6YG's debt to equity ratio has reduced from 33.4% to 13% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6YG has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 6YG has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.